NEW YORK, NY--(Marketwire - July 09, 2012) - Kadmon Corporation, LLC, today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the JMP Securities Healthcare Conference on Thursday, July 12th at 1:00 p.m. Eastern Time at the Peninsula Hotel in New York City. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon’s website at www.kadmon.com. The webcast will be archived for 90 days.
About Kadmon Corporation
Kadmon Corporation, LLC is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C. Kadmon is pioneering medicines in oncology, infectious diseases, immunology and neurodegenerative diseases by using emerging concepts in molecular biology and genomics to develop therapies that target the metabolomics and signaling pathways associated with disease. For more information, visit www.kadmon.com.
Contact Information
For Kadmon Corporation:
David Pitts
Argot Partners
212.600.1902
Email Contact
